Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VOLC
2026
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $970K | ﹤0.01% |
40,500
-998,800
| -96% | -$21.3M |
|
2027
BK Technologies
BKTI
$292M
| $969K | ﹤0.01% |
73,380
+10,500
| +17% | +$157K |
|
|
BLMT
2028
DELISTED
BSB Bancorp, Inc.
BLMT
| $967K | ﹤0.01% |
69,024
+12,538
| +22% | +$174K |
|
2029
HealthStream
HSTM
$829M
| $958K | ﹤0.01% |
25,299
-40,701
| -62% | -$1.33M |
|
2030
First Busey Corp
BUSE
$2.58B
| $957K | ﹤0.01% |
61,200
-26,962
| -31% | -$400K |
|
2031
SAP
SAP
$242B
| $954K | ﹤0.01% |
12,900
-143,900
| -92% | -$10.6M |
|
|
SBSA
2032
DELISTED
Spanish Broadcasting System Inc.
SBSA
| $953K | ﹤0.01% |
233,020
-1,600
| -0.7% | -$6.03K |
|
|
CAI
2033
DELISTED
CAI International, Inc.
CAI
| $952K | ﹤0.01% |
+40,900
| New | +$914K |
|
|
STB
2034
DELISTED
Student Transportation Inc
STB
| $951K | ﹤0.01% |
151,200
+137,288
| +987% | +$870K |
|
2035
RPC Inc
RES
$1.4B
| $949K | ﹤0.01% |
61,319
-233,600
| -79% | -$3.42M |
|
2036
Northrim BanCorp
NRIM
$599M
| $947K | ﹤0.01% |
157,200
+22,276
| +17% | +$137K |
|
2037
Kelly Services Class A
KELYA
$536M
| $943K | ﹤0.01% |
+48,408
| New | +$920K |
|
2038
Federal Signal
FSS
$7.71B
| $942K | ﹤0.01% |
+73,200
| New | +$803K |
|
|
DM
2039
DELISTED
DOLAN COMPANY COMMON STOCK
DM
| $939K | ﹤0.01% |
415,400
-283,500
| -41% | -$635K |
|
|
ECYT
2040
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $938K | ﹤0.01% |
70,400
+43,900
| +166% | +$694K |
|
|
SPAN
2041
DELISTED
Span-America Medical Systems I
SPAN
| $938K | ﹤0.01% |
43,600
+4,200
| +11% | +$88.4K |
|
|
COWN
2042
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $936K | ﹤0.01% |
+68,028
| New | +$908K |
|
|
GPIC
2043
DELISTED
Gaming Partners International Corporation
GPIC
| $933K | ﹤0.01% |
115,000
-100
| -0.1% | -$819 |
|
|
OME
2044
DELISTED
Omega Protein
OME
| $932K | ﹤0.01% |
91,600
-108,800
| -54% | -$1.02M |
|
|
FPP
2045
DELISTED
FieldPoint Petroleum Corporation
FPP
| $930K | ﹤0.01% |
206,600
+11,900
| +6% | +$51.4K |
|
|
CRESY
2046
Cresud
CRESY
$759M
| $928K | ﹤0.01% |
120,679
-47,429
| -28% | -$336K |
|
2047
Spire
SR
$4.89B
| $927K | ﹤0.01% |
20,600
-5,711
| -22% | -$258K |
|
2048
LG Display
LPL
$3.37B
| $926K | ﹤0.01% |
77,600
-72,100
| -48% | -$906K |
|
|
GLPW
2049
DELISTED
GLOBAL POWER EQUIPMENT GROUP INC COMMON NEW
GLPW
| $924K | ﹤0.01% |
+45,957
| New | +$844K |
|
|
ARDNA
2050
DELISTED
ARDEN GROUP INC CL-A
ARDNA
| $923K | ﹤0.01% |
7,100
| – | – |
|
Similar funds
Jim Simons's Q3 2013 Portfolio in Review
As of Q3 2013, Jim Simons held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Jim Simons added most to IBM in Q3 2013, an estimated $328M increase.
- Jim Simons's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Jim Simons fully exited Apple in Q3 2013, selling an estimated $283M.
- Jim Simons's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Jim Simons opened 439 new positions and closed 412 in Q3 2013.
- Jim Simons's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.